Brighter AB (publ): Decision from Nasdaq Stockholm's disciplinary board imposes a fine on Brighter of 8 annual fees corresponding to approx. 1,5 MSEK
Brighter AB (publ.) ("Brighter" or "the company") announced today that Nasdaq Stockholm's disciplinary committee has decided to impose a fine on Brighter as a result of the company's handling of information on different occasions since 2020.
The stock exchange has claimed that Brighter violated the Regulations by not publishing insider information in the correct way and by holding the general meeting too late.
For more information, please contact:
Investor Relations
IR@brighter.se
Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB, www.mangold.se
About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.For more information, please visit our website at www.brighter.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 23 November at 09:15 CEST